Christopher Kearney MD, MPH
Assistant Professor, Pulmonary, Allergy, Sleep & Critical Care Medicine
72 East Concord Street | (617) 358-2800cmkearne@bu.edu
Sections
Pulmonary, Allergy, Sleep & Critical Care Medicine
Education
MD, Harvard Medical School
MPH, Harvard School of Public Health
Mathematics/Biology, BS, Villanova University
Publications
Kearney CM, Sangani R, Shankar D, O'Connor GT, Law AC, Walkey AJ, Bosch NA. Comparative Effectiveness of Mepolizumab, Benralizumab and Dupilumab among Patients with Difficult-to-Control Asthma. Ann Am Thorac Soc. 2024 Jan 19. PMID: 38241013.
Published on 6/1/2023Pang B, Kearney L, Maccarone J, Zhang J, Kearney C, Sangani R, Shankar DA, Gillmeyer KR, Law AC, Bosch NA. Association between Early Venous Thromboembolism Prophylaxis, Bleeding Risk, and Venous Thromboembolism among Critically Ill Patients with Thrombocytopenia. Ann Am Thorac Soc. 2023 Jun; 20(6):917-920. PMID: 36867519.
Published on 3/1/2023Kearney C, Lesieur M, Bosch NA, Walkey AJ. Corticosteroid Uptake For COVID-19 after Publication of RECOVERY: A Difference in Difference Model. Ann Am Thorac Soc. 2023 Mar; 20(3):473-476. PMID: 36525470.
Media Mentions
Published on 3/7/2024
Dupilumab outperforms other biologics in reducing asthma exacerbation rate
Published on 4/26/2023
Corticosteroid uptake rapid for patients hospitalized with COVID-19 following trial data
View full list of 2 media mentions.